Quick Answer
HCW Biologics Inc. reported Gross Profit of $10.8 thousand for the year ending 2025.
- HCW Biologics Inc. showed a decrease of -98.9% in Gross Profit from 2024 to 2025.
- This data is from HCW Biologics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.00 | Q2 2021: $0.00 | Q3 2021: $0.00 | Q1 2022: $1.79 million | Q2 2022: $166.8 thousand | Q3 2022: $361.8 thousand | Q1 2023: $12.5 thousand | Q2 2023: $120.4 thousand | Q3 2023: $174.8 thousand | Q1 2024: $614.7 thousand | Q2 2024: $180.4 thousand | Q3 2024: $85.3 thousand | Q1 2025: $1.0 thousand | Q2 2025: $1.3 thousand | Q3 2025: $3.1 thousand.
- Historical annual values: Fiscal year 2025: $10.8 thousand | Fiscal year 2024: $959.4 thousand | Fiscal year 2023: $560.4 thousand | Fiscal year 2022: $2.59 million | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: